MCCORMICK FRANK - Insider Non-Derivative Transactions at BridgeBio Pharma, Inc. (BBIO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 29, 2025, MCCORMICK FRANK's relationship to BridgeBio Pharma, Inc. (BBIO) is Director, and currently has 766,583 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BBIO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

MCCORMICK FRANK - Insider Non-Derivative Transactions of BBIO Common Stock

MCCORMICK FRANK - Insider Non-Derivative Transactions at BBIO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 30, 2025	Sell -- (Common Stock)	43393	69.24	679979
Oct 30, 2025	Sell -- (Common Stock)	8598	68.5	723372
Oct 30, 2025	Sell -- (Common Stock)	3497	67.52	731970
Oct 30, 2025	Sell -- (Common Stock)	31116	66.2	735467
Oct 30, 2025	Sell -- (Common Stock)	111755	65.48	766583
Oct 28, 2025	Sell -- (Common Stock)	1641	65	878338
Sep 6, 2025	Sell -- (Common Stock)	74000	53.16	83275
Sep 6, 2025	M -- (Common Stock)	74000	11.92	157275
Jun 25, 2025	Sell -- (Common Stock)	100000	44.23	879979
Jun 21, 2025	Acquisition -- (Common Stock)	6589	0	83.28
May 9, 2025	G -- (Common Stock)	3000	0	76686
May 8, 2025	G -- (Common Stock)	33000	0	79686
Dec 27, 2024	G -- (Common Stock)	7400	0	112686
Dec 27, 2024	G -- (Common Stock)	7400	0	464976
Dec 27, 2023	Sell -- (Common Stock)	100000	42.06	627689